Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Aims To Establish Overseas Staff Posts, Starting In China

This article was originally published in The Gray Sheet

Executive Summary

FDA is considering posting staff overseas to perform inspections and foster relationships with foreign government counterparts and industry

You may also be interested in...



State Department Approves FDA Request To Place Staff In China

The ball is in China's court now to authorize eight new permanent, full-time FDA positions at U.S. diplomatic posts in China

State Department Approves FDA Request To Place Staff In China

The ball is in China's court now to authorize eight new permanent, full-time FDA positions at U.S. diplomatic posts in China

FDA Inspections Of Foreign Device Manufacturers Anemic – GAO Testimony

FDA's effectiveness in conducting device manufacturing inspections overseas was criticized by the Government Accountability Office in testimony before Congress that found overall "weaknesses" in the agency's inspection of medical device manufacturers

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025647

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel